Ratings for Immunocore Hldgs (NASDAQ:IMCR) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $86.44, a high estimate of $100.00, and a low estimate of $66.00. This current average represents a 0.77% decrease from the previous average price target of $87.11. U…